Sample size and power based on the population attributable fraction.
- 1 September 1989
- journal article
- research article
- Published by American Public Health Association in American Journal of Public Health
- Vol. 79 (9) , 1289-1294
- https://doi.org/10.2105/ajph.79.9.1289
Abstract
Most methods for calculating sample size use the relative risk (RR) to indicate the strength of the association between exposure and disease. For measuring the public health importance of a possible association, the population attributable fraction (PAF)--the proportion of disease incidence in a population that is attributable to an exposure--is more appropriate. We determined sample size and power for detecting a specified PAF in both cohort and case-control studies and compared the results with those obtained using conventional estimates based on the relative risk. When an exposure is rare, a study that has little power to detect a small RR often has adequate power to detect a small PAF. On the other hand, for common exposures, even a relatively large study may have inadequate power to detect a small PAF. These comparisons emphasize the importance of selecting the most pertinent measure of association, either relative risk or population attributable fraction, when calculating power and sample size.This publication has 24 references indexed in Scilit:
- Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: Final report of the pooling projectPublished by Elsevier ,2004
- Summary attributable risk estimation from unmatched case‐control dataStatistics in Medicine, 1988
- Variance estimators for attributable fraction estimates consistent in both large strata and sparse dataStatistics in Medicine, 1987
- SERUM CHOLESTEROL, BLOOD PRESSURE, AND MORTALITY: IMPLICATIONS FROM A COHORT OF 361 662 MENThe Lancet, 1986
- Sample size determination in case-control studies: The influence of the distribution of exposureJournal of Chronic Diseases, 1985
- The Design of Case-Control Studies: The Influence of Confounding and Interaction EffectsInternational Journal of Epidemiology, 1984
- Menopausal Estrogen Therapy and Hip FracturesAnnals of Internal Medicine, 1981
- Introduction to sample size determination and power analysis for clinical trialsControlled Clinical Trials, 1981
- The occurrence of lung cancer in man.1953